Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

15.6%

387 terminated/withdrawn out of 2481 trials

Success Rate

79.0%

-7.5% vs industry average

Late-Stage Pipeline

9%

221 trials in Phase 3/4

Results Transparency

44%

647 of 1457 completed trials have results

Key Signals

340 recruiting647 with results207 terminated180 withdrawn

Enrollment Performance

Analytics

N/A
1178(58.5%)
Phase 2
319(15.8%)
Phase 1
246(12.2%)
Phase 4
131(6.5%)
Phase 3
90(4.5%)
Early Phase 1
50(2.5%)
2014Total
N/A(1178)
Phase 2(319)
Phase 1(246)
Phase 4(131)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2481)

Showing 20 of 2481 trials
NCT07737535Active Not Recruiting

Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis

Role: lead

NCT04753320Not Yet Recruiting

Remote Monitoring in Progressive Supranuclear Palsy (PSP)

Role: collaborator

NCT07699146Not ApplicableNot Yet Recruiting

HEARS Maryland: Extending Capacity for Affordable, Accessible Hearing Care Through Older Adult Peer Mentorship

Role: lead

NCT07157982Not ApplicableEnrolling By Invitation

Living With Multimorbidity: Care Coordination and Symptom Management Program (COORDINATE)

Role: lead

NCT07734870Phase 2Not Yet Recruiting

Tirzepatide for Treatment of CCCA

Role: lead

NCT04162938Not ApplicableRecruiting

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

Role: lead

NCT06457048Not ApplicableCompleted

Zambia Stroke Unit Study

Role: lead

NCT07232069Phase 3Recruiting

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Role: collaborator

NCT05324982Phase 1Completed

Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants

Role: collaborator

NCT05153967Recruiting

Cooperative Assessment of Late Effects for SCD Curative Therapies

Role: collaborator

NCT06089707Phase 3Active Not Recruiting

Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl

Role: collaborator

NCT02675959Phase 2Recruiting

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Role: collaborator

NCT07503002Phase 1Not Yet Recruiting

Shortened LSD Intervention for Major Depressive Disorder

Role: lead

NCT06355414Phase 1Recruiting

Psilocybin in Chronic Low Back Pain and Depression

Role: lead

NCT07725224Not ApplicableNot Yet Recruiting

Use of a Smartphone App to Support Pre- and Post-Surgical Preparedness and to Improve Clinical Outcomes in Patients Undergoing Shoulder Arthroscopy

Role: lead

NCT02244411Not ApplicableCompleted

Exercise and QUality Diet After Leukemia: The EQUAL Study

Role: collaborator

NCT07726173Not ApplicableRecruiting

Transventricular Off-pump Mitral Valve Repair

Role: lead

NCT03730181Phase 1Completed

Tuberculosis Clinical Trials Consortium Study 35

Role: collaborator

NCT03090646Not ApplicableTerminated

Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance

Role: lead

NCT07391904Not ApplicableEnrolling By Invitation

Patient-centered Precision Medicine Lab Result Communication for Older Adults

Role: collaborator